Evidence supporting the use of: Lily of the Valley
For the health condition: Cardiac Arrest

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 1

Lily of the Valley (Convallaria majalis) has a long-standing history of use in traditional herbal medicine, particularly in Europe, where it was used as a cardiac tonic. The plant contains cardiac glycosides, primarily convallatoxin, which have effects similar to those of digitalis (from foxglove). These compounds act on the heart by increasing the force of contraction and can influence heart rhythm. Historically, Lily of the Valley was used to manage various heart conditions, including congestive heart failure and arrhythmias, and by extension, was sometimes considered in severe cardiac events.

However, there is no robust modern scientific evidence supporting the use of Lily of the Valley specifically for the treatment of cardiac arrest—a sudden, life-threatening cessation of heart function. Cardiac arrest requires immediate advanced medical intervention, such as CPR and defibrillation, and is not treatable with herbal remedies. While the pharmacological activity of cardiac glycosides is established, their narrow therapeutic window and toxicity profile make unsupervised or traditional use potentially dangerous.

In summary, the use of Lily of the Valley for heart conditions, including cardiac arrest, is rooted in historical tradition rather than validated by current clinical research, and its application in acute cardiac emergencies is not supported by contemporary medical practice.

More about Lily of the Valley
More about Cardiac Arrest

Products containing Lily of the Valley

We currently have no products on Vitabase that contain this ingredient.